MilliporeSigma to use gene editing to make more cell lines resistant to viruses
MilliporeSigma plans to use gene editing to help developers make cell lines resistant to viruses that cost manufacturers millions in contaminated products.
Archives for September 15, 2016
Promising Korea? CMO giant Samsung Biologics opens doors to Biopharma-Reporter
Since 2011, Samsung Biologics has built two plants, gained Bristol-Myers Squibb and Roche as clients and launched an IPO. With a third facility under construction, Biopharma-Reporter visited to see the CMO’s ambition in action.
Rentschler doubles capacity with new manufacturing plant
Rentschler Biotechnologie has opened a facility at its site in Laupheim, Germany and plans to create 200 new jobs.